Wednesday, January 28, 2009
Consolidated Net Profit At Rs 107.4 Cr In Third Quarter
Q3 Sales Surge By 19.4% To Rs 786.21 Cr
Announces 75% Interim Dividend
New Delhi, January 28th, 2009: The Board of Directors of Dabur India Ltd (DIL) met here today to consider the audited financial results of the company for the quarter and nine months ending December 31, 2008.
Riding on strong performance in key categories like Hair Care (both hair oils & shampoos), Skin Care and Home Care; coupled with a softening of input costs and robust growth in the international markets, Dabur India Ltd reported a strong 19.4% growth in its consolidated sales for the third quarter ended December 31, 2008. Dabur ended the quarter with gross sales of 786.21 Crore, up from Rs 658.61 Crore a year earlier. Net profit for the third quarter marked a 16.1% surge to Rs 107.40 Crore, up from Rs 92.50 Crore a year ago.
The board of directors of Dabur India Ltd also declared an Interim Dividend of 75% for the current financial year. “With a firm focus on internal efficiencies and our key growth drivers, we have been able to achieve impressive growth this quarter. Continuing with our payout policy, Dabur India has approved an Interim Dividend of 75% for the year, aggregating to a payout of Rs 64.88 Crore,” said Dabur India Ltd Chairman Dr Anand Burman.
“We continue to sustain our growth momentum and reported strong top line and bottom line improvements during the third quarter. Our Hair Care business continued to surge ahead with a strong 29% growth during the quarter, led by shampoos that grew by a robust 34%. The Baby & Skin Care category, led by strong demand for our recent skin care introductions under the Gulabari brand, also reported a 24% growth during the period. Even in the current economic scenario, demand for our everyday use products continue to be strong and we have not seen any significant impact on consumer spending,” Dabur India Ltd CEO Mr. Sunil Duggal said.
The Consumer Health Division too continued to surge ahead, reporting a near 18% growth during the quarter. Dabur’s International Business, Mr. Duggal added, also grew at a rapid pace with the division recording an impressive 48.2% growth during the third quarter, led by powerhouse performance in GCC and North African markets.
The quarter saw Dabur India Ltd roll out a host of new products and initiatives. Dabur India introduced a new Pudina flavour in its Hajmola digestive category, besides announcing the national rollout of its malted food drink, Dabur Chyawan Junior, which met with encouraging response in the market.
During the quarter, Dabur India also announced the acquisition of 72.15% of Fem Care Pharma Ltd, a leading player in the women’s skin care products market, for Rs 203.7 Crores in an all-cash deal.
Dabur India Ltd Group Director Mr. P D Narang, who has been appointed as an Observer on the Fem Care Pharma board, said the Open Offer for 20% additional equity in Fem Care Pharma has been announced and Fem is expected to operate as a subsidiary of Dabur India Ltd from April 2009.
About Dabur India Ltd
Dabur India Limited is one of India’s leading FMCG Companies. Building on a legacy of quality and experience for over 120 years, Dabur is today India’s most trusted name and the world’s largest Ayurvedic and Natural Health Care Company. Dabur India's FMCG portfolio today includes flagship brands with distinct brand identities -- Dabur as the master brand for natural healthcare products, Vatika for premium personal care, Hajmola for digestives, and Réal for fruit-based beverages.
For Details :
Mr. Byas Anand Corporate Communications Dabur India Limited PH:- 95120-3982000, 3001000 extn 2101/2547 Fax: 95120-4374935 Email:email@example.com